Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvals
{{output}}
Background: This study examines whether single-agent activity in early clinical phases correlates with the approval likelihood of combination therapies in oncology. Using the Intelligencia AI database, we investigated the impact ... ...
